| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2016-08-22 | AZD3293 | Alzheimer's disease | 3 | AstraZeneca (UK) Eli Lilly (USA - IN) | Neurodegenerative diseases |
| 2016-08-17 | AT132 | X-linked myotubular myopathy (XLMTM) | 1 | Audentes Therapeutics (USA - CA) | Rare diseases - Genetic diseases - Neuromuscular diseases |
| 2016-08-16 | SFX-01 | breast cancer | 1-2 | Evgen Pharma (UK) | Cancer - Oncology |
| 2016-08-15 | LGD-6972 | type 2 diabetes | 1b | Ligand Pharmaceuticals (USA - CA) | Metabolic diseases |
| 2016-08-15 | BI 695501 (biosimilar version of Humira® (adalimumab)) | Crohn's disease | 3 | Boehringer Ingelheim (Germany) | Autoimmune diseases - Inflammatory diseases - Digestive diseases |
| 2016-08-15 | Praxbind® (idarucizumab) | specific antidote for Pradaxa® - reversion of the anticoagulant effect of dabigatran due to uncontrolled life-threatening bleeding requiring urgent intervention or a need to undergo an emergency surgery/urgent invasive procedure. | Boehringer Ingelheim (Germany) | Cardiovascular diseases - Cerebrovascular diseases | |
| 2016-08-11 | TransCon Growth Hormone | growth hormone deficiency | 3 | Ascendis Pharma (Denmark) | Endocrine diseases - Hormonal diseases |
| 2016-08-11 | tazemetostat - EPZ-6438 (E7438) | mesothelioma characterized by BAP1 loss-of-function | 2 | Epizyme (USA - MA) | Cancer - Oncology |
| 2016-08-11 | INO-4212 | Ebola fever | 1 | Inovio Pharmaceuticals (USA - PA) GeneOne Life Science (South Korea) | Infectious diseases |
| 2016-08-11 | dasiglucagon (ZP4207) | severe hypoglycemia in insulin dependent diabetic patients | 2 | Zealand Pharma (Denmark) | Metabolic diseases |
| 2016-08-10 | migalastat | Fabry disease | 3 | GSK (UK) Amicus Therapeutics (USA - NJ) | Rare diseases - Genetic diseases |
| 2016-08-10 | MOB-015 (topical formulation of terbinafine) | onychomycosis | 3 | Moberg Pharma (Sweden) | Infectious diseases |
| 2016-08-10 | AMV564, | acute myeloid leukemia (AML) | 1 | Amphivena Therapeutics (USA - CA) | Cancer - Oncology |
| 2016-08-10 | RST-001 | retinitis pigmentosa | 1-2 | RetroSense Therapeutics (USA - MA) | Rare diseases - Genetic diseases - Ophtalmological diseases |
| 2016-08-09 | selumetinib and docetaxel | KRAS mutation-positive and metastatic non small cell lung cancer | 3 | AstraZeneca (UK) | Cancer - Oncology |
| 2016-08-08 | Jetrea® (ocriplasmin) | vitreomacular adhesion including macular hole | 3 | Thrombogenics (Belgium) | Ophtalmological diseases |
| 2016-08-08 | Permaderm™ (Engineered Skin Substitute - ESS) | full-thickness (dermal and epidermal layers of skin) life-threatening pediatric severe burns covering a total body surface area (TBSA) of 50% or greater | Amarantus BioScience (USA – CA) | Dermatological diseases | |
| 2016-08-08 | PF582 ( biosimilar ranibizumab ) | age related macular degeneration (AMD) | 1-2 | Pfenex (USA - CA) | Ophtalmological diseases |
| 2016-08-08 | Px563L | anthrax | 1a | Pfenex (USA - CA) | Infectious diseases |
| 2016-08-07 | GBT440 | sickle cell disease | preclinical | Global Blood Therapeutics (USA - CA) | Rare diseases - Genetic diseases - Hematological diseases |
